Trial Details
COMPLETEDBasic Information
| Clinical ID | c780 |
|---|---|
| Identifier | NCT02289417 |
| Trial Title | Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Apremilast|DRUG: Placebo |
Participant Information
| Sponsor | Amgen |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-01-08 |
|---|---|
| Primary Completion Date | 2017-09-25 |
| Completion Date | 2019-06-03 |